174 related articles for article (PubMed ID: 22942745)
21. Dual regulation of TRPV1 channels by phosphatidylinositol via functionally distinct binding sites.
Yazici AT; Gianti E; Kasimova MA; Lee BH; Carnevale V; Rohacs T
J Biol Chem; 2021; 296():100573. PubMed ID: 33766560
[TBL] [Abstract][Full Text] [Related]
22. A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation.
Klionsky L; Tamir R; Holzinger B; Bi X; Talvenheimo J; Kim H; Martin F; Louis JC; Treanor JJ; Gavva NR
J Pharmacol Exp Ther; 2006 Oct; 319(1):192-8. PubMed ID: 16844842
[TBL] [Abstract][Full Text] [Related]
23. TRPV1: Structure, Endogenous Agonists, and Mechanisms.
Benítez-Angeles M; Morales-Lázaro SL; Juárez-González E; Rosenbaum T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408609
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
[TBL] [Abstract][Full Text] [Related]
25. Rational design and validation of a vanilloid-sensitive TRPV2 ion channel.
Yang F; Vu S; Yarov-Yarovoy V; Zheng J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3657-66. PubMed ID: 27298359
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch.
Morales-Lázaro SL; Llorente I; Sierra-Ramírez F; López-Romero AE; Ortíz-Rentería M; Serrano-Flores B; Simon SA; Islas LD; Rosenbaum T
Nat Commun; 2016 Oct; 7():13092. PubMed ID: 27721373
[TBL] [Abstract][Full Text] [Related]
27. Functional transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 channels along different segments of the renal vasculature.
Chen L; Kaßmann M; Sendeski M; Tsvetkov D; Marko L; Michalick L; Riehle M; Liedtke WB; Kuebler WM; Harteneck C; Tepel M; Patzak A; Gollasch M
Acta Physiol (Oxf); 2015 Feb; 213(2):481-91. PubMed ID: 25069877
[TBL] [Abstract][Full Text] [Related]
28. Engineering vanilloid-sensitivity into the rat TRPV2 channel.
Zhang F; Hanson SM; Jara-Oseguera A; Krepkiy D; Bae C; Pearce LV; Blumberg PM; Newstead S; Swartz KJ
Elife; 2016 May; 5():. PubMed ID: 27177419
[TBL] [Abstract][Full Text] [Related]
29. Activation of transient receptor potential vanilloid 1 decreases endothelial nitric oxide synthase phosphorylation at Thr497 by protein phosphatase 2B-dependent dephosphorylation of protein kinase C.
Ching LC; Zhao JF; Su KH; Shyue SK; Hsu CP; Lu TM; Lin SJ; Lee TS
Acta Physiol (Oxf); 2013 Oct; 209(2):124-35. PubMed ID: 24028645
[TBL] [Abstract][Full Text] [Related]
30. Location and Character of Volatile General Anesthetics Binding Sites in the Transmembrane Domain of TRPV1.
Jorgensen C; Domene C
Mol Pharm; 2018 Sep; 15(9):3920-3930. PubMed ID: 30067911
[TBL] [Abstract][Full Text] [Related]
31. Computational Modeling to Explain Why 5,5-Diarylpentadienamides are TRPV1 Antagonists.
Caballero J
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801115
[TBL] [Abstract][Full Text] [Related]
32. 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands.
Kim C; Ann J; Lee S; Kim E; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem; 2018 Aug; 26(15):4509-4517. PubMed ID: 30078610
[TBL] [Abstract][Full Text] [Related]
33. Discovery of (S)-N-(3-isopropylphenyl)-2-(5-phenylthiazol-2-yl)pyrrolidine-1-carboxamide as potent and brain-penetrant TRPV1 antagonist.
Qiao Y; Zhang Y; Qiao Z; He W; Chen Y; Song D; Wang G; Guo N; Shao L; Tian Z; Wang Q; Yan L; Qian H
Eur J Med Chem; 2022 Apr; 233():114191. PubMed ID: 35263708
[TBL] [Abstract][Full Text] [Related]
34. Integrative binding sites within intracellular termini of TRPV1 receptor.
Grycova L; Holendova B; Bumba L; Bily J; Jirku M; Lansky Z; Teisinger J
PLoS One; 2012; 7(10):e48437. PubMed ID: 23119017
[TBL] [Abstract][Full Text] [Related]
35. Heat activation is intrinsic to the pore domain of TRPV1.
Zhang F; Jara-Oseguera A; Chang TH; Bae C; Hanson SM; Swartz KJ
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E317-E324. PubMed ID: 29279388
[TBL] [Abstract][Full Text] [Related]
36. Molecular modeling of the full-length human TRPV1 channel in closed and desensitized states.
Fernández-Ballester G; Ferrer-Montiel A
J Membr Biol; 2008 Jun; 223(3):161-72. PubMed ID: 18791833
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) binding to transient receptor potential V1 (TRPV1) channels.
Poblete H; Oyarzún I; Olivero P; Comer J; Zuñiga M; Sepulveda RV; Báez-Nieto D; González Leon C; González-Nilo F; Latorre R
J Biol Chem; 2015 Jan; 290(4):2086-98. PubMed ID: 25425643
[TBL] [Abstract][Full Text] [Related]
38. Molecular determinants of vanilloid sensitivity in TRPV1.
Gavva NR; Klionsky L; Qu Y; Shi L; Tamir R; Edenson S; Zhang TJ; Viswanadhan VN; Toth A; Pearce LV; Vanderah TW; Porreca F; Blumberg PM; Lile J; Sun Y; Wild K; Louis JC; Treanor JJ
J Biol Chem; 2004 May; 279(19):20283-95. PubMed ID: 14996838
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine Residue in the TRPV1 Vanilloid Binding Pocket Regulates Deactivation Kinetics.
Kumar R; Hazan A; Basu A; Zalcman N; Matzner H; Priel A
J Biol Chem; 2016 Jun; 291(26):13855-63. PubMed ID: 27143360
[TBL] [Abstract][Full Text] [Related]
40. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism.
Xu H; Blair NT; Clapham DE
J Neurosci; 2005 Sep; 25(39):8924-37. PubMed ID: 16192383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
